Trusted Migraine Formula, MigreLief Triple Therapy with Puracol™- Now Distributed Exclusively Through Patent Holder, Akeso Health Sciences, LLC.

Share Article

Akeso Health Sciences of Westlake Village, California announces they are now the exclusive distributor of MigreLief with Puracol™ their patented migraine formula.

Akeso MigreLief Original Formula with Puracol™

Akeso MigreLief Original Formula with Puracol™

Akeso Health Sciences, LLC, the developer and patent holder of the nonprescription migraine formula known for the last 15 years as “MigreLief” announces it is now the sole and exclusive worldwide distributor of the product which contains the patented formula of high dose riboflavin, two sources of magnesium and Puracol™ feverfew.

Akeso no longer licenses the right to any company to sell the patented MigreLief with Puracol™ product under any name other than Akeso. Akeso’s patented formula has been recommended for over 15 years by healthcare professionals including neurologists and headache specialists and used by tens of thousands of migraine patients in the United States and worldwide.

People who have come to rely upon the nonprescription, dietary supplement MigreLief with Puracol™ and would like to continue using it, should closely read the label for the AKESO name and “Puracol™” branding. For chronic migraine sufferers, MigreLief Original Formula - Triple Therapy with Puracol™ can be purchased online by visiting Akeso’s website, or other online vendors, by using the store locator at MigreLief.US to locate one of the 3,000+ independent pharmacies nationwide that sell MigreLief with Puracol™ or by calling 1-800-758-8746. Companies who would like to resell MigreLief with Puracol™ may also call 1-800-758-8746

Akeso Health Sciences, LLC specializes in developing dietary supplements providing nutritional support for men, women and children age 2+ who suffer from migraines.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Curt Hendrix
since: 10/2009
Follow >
since: 02/2010
Like >
Visit website